Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 709 of 767

Advanced search

🌍Jan 11, 2025Industrymatinasbiopharma.comTier 1 · Company source

Matinas BioPharma Receives NYSE Noncompliance Notice

Matinas BioPharmaOriginal source

🌍Jan 11, 2025Regulatoryima.isTier 1 · Regulatory source

RMS requests and national applications

IMA IcelandOriginal source

🇺🇸Jan 10, 2025Industrylighthorsetx.comTier 1 · Company source

Light Horse Therapeutics Debuts With $62 Million Series A Financing

Light Horse TherapeuticsOriginal source

🌍Jan 10, 2025Mediavirgosvs.comTier 2 · Direct publisher

Introducing EndoDINO: A Breakthrough in Endoscopic AI

VirgoOriginal source

🇺🇸Jan 9, 2025Industrylighthorsetx.comTier 1 · Company source

Light Horse Therapeutics Enters Into Strategic Collaboration With Novartis

Light Horse TherapeuticsOriginal source

🌍Jan 9, 2025Industrynimbustx.comTier 1 · Company source

Nimbus Therapeutics Announces Clinical Progress in Oncology Therapeutic Pipeline and Provides Business Updates

Nimbus TherapeuticsOriginal source

🇨🇭Jan 9, 2025Industryalentis.chTier 1 · Company source

Alentis Announces Positive Topline Results from Two Studies of Lixudebart (ALE.F02) in Patients with ANCA-RPGN and Advanced Liver Fibrosis

Alentis TherapeuticsOriginal source

🌍Jan 9, 2025Mediavirgosvs.comTier 2 · Direct publisher

DINOv2 and the AI Revolution in Healthcare

VirgoOriginal source

🇺🇸Jan 8, 2025Industrysolidbio.comTier 1 · Company source

Letter to the FA Community

Solid BiosciencesOriginal source

🌍Jan 7, 2025Mediavirgosvs.comTier 2 · Direct publisher

The Untapped Potential of Endoscopy Videos in Precision Medicine

VirgoOriginal source

🇺🇸Jan 7, 2025Industrycapsida.comTier 1 · Company source

Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration

Capsida BiotherapeuticsOriginal source

🌍Jan 7, 2025Mediavirgosvs.comTier 2 · Direct publisher

How AI is Transforming GI Research

VirgoOriginal source

🇮🇱Jan 5, 2025Devicesmedinol.comTier 1 · Company source

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

MedinolOriginal source

🌍Jan 3, 2025Industrycorbus.comTier 1 · Company source

Overcoming Barriers to Supply Chain Integration

Corbus PharmaceuticalsOriginal source

🌍Jan 2, 2025Industryperspective.comTier 1 · Company source

2023 Year In Review — Perspective Group

Perspective TherapeuticsOriginal source

🌍Jan 2, 2025Industryperspective.comTier 1 · Company source

2022 Year In Review — Perspective Group

Perspective TherapeuticsOriginal source

🌍Dec 27, 2024Regulatorysocra.orgTier 1 · Regulatory source

SOCRA 2024 Year in Review & What to Expect in 2025

SOCRA SocietyOriginal source

🇺🇸Dec 25, 2024Devicesfoundationmedicine.comTier 1 · Company source

Forging Forward - Our Progress in Biopharmaceutical Partnerships and Outlook for Success in 2025

Foundation MedicineOriginal source

🇺🇸Dec 23, 2024Industryexeevo.comTier 1 · Company source

How to use cross-selling to drive HCP engagement

ExeevoOriginal source

🇺🇸Dec 23, 2024Devicesaccuray.comTier 1 · Company source

The Royal Marsden NHS Foundation Trust: Embracing Technological Advancements in Radiation Therapy

AccurayOriginal source

🌍Dec 20, 2024Regulatoryravimiamet.eeTier 1 · Regulatory source

Estonia's Drug Utilization Research Practices Receive International Recognition

SAM EstoniaOriginal source

🇺🇸Dec 20, 2024Devicesaccuray.comTier 1 · Company source

Record-Breaking Attendance at Accuray French-speaking Users Meeting

AccurayOriginal source

🌍Dec 19, 2024Regulatoryacrohealth.orgTier 1 · Regulatory source

ACRO Announces 2025 Officers and New Members

ACRO AssociationOriginal source

🇺🇸Dec 19, 2024Industrycapsida.comTier 1 · Company source

Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Capsida BiotherapeuticsOriginal source

🌍Dec 18, 2024Industryintercure.coTier 1 · Company source

Extraordinary General Meeting of shareholders to be held on October 28, 2024

InterCureOriginal source

🌍Dec 17, 2024Industryblueprintgenetics.comTier 1 · Company source

Our service hours during the holidays 2024-2025

Blueprint Genetics (Quest Diagnostics)Original source

🇺🇸Dec 13, 2024Industryexeevo.comTier 1 · Company source

AI Agents: Enhancing Life Sciences Productivity

ExeevoOriginal source

🌍Dec 13, 2024Devicesdigitaldiagnostics.comTier 1 · Company source

Keep an eye on diabetic retinopathy

IDx (Digital Diagnostics)Original source

🌍Dec 13, 2024Regulatoryacrohealth.orgTier 1 · Regulatory source

ACRO Releases Publication Showcasing Benefits of Centralized Monitoring Implementation Through Real-World Use Case

ACRO AssociationOriginal source

🇨🇭Dec 12, 2024Industryalentis.chTier 1 · Company source

Alentis Announces Publication of a Review Paper on Tight Junction Proteins and Kidney Disease in Nephron

Alentis TherapeuticsOriginal source

🇺🇸Dec 12, 2024Industrygenesis.mlTier 3 · Secondary coverage

Genesis Therapeutics Expands Leadership Team with Appointments of Chief Scientific Officer, SVP of Engineering, and Board Chairman

Genesis TherapeuticsOriginal source

🌍Dec 11, 2024Regulatorysocra.orgTier 1 · Regulatory source

Navigating the Critical Role of Quality Assurance in Clinical Trials: Best Practices, Challenges, and Emerging Trends

SOCRA SocietyOriginal source

🇺🇰Dec 11, 2024Industryowlstonemedical.comTier 1 · Company source

September through December at Owlstone Medical

Owlstone Medical (Breath Biopsy AI)Original source

🇺🇰Dec 11, 2024Industryowlstonemedical.comTier 1 · Company source

Highlights from a Busy Summer

Owlstone Medical (Breath Biopsy AI)Original source

🇮🇱Dec 10, 2024Devicesmedinol.comTier 1 · Company source

5-Year Outcomes from the BIONICS and NIREUS Trials

MedinolOriginal source

🌍Dec 10, 2024Industryintercure.coTier 1 · Company source

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

InterCureOriginal source

🇯🇵Dec 9, 2024Deviceshoya.comTier 1 · Company source

HOYA Corporation acquired the remaining shares of PLASMABIOTICS SAS

HOYA CorporationOriginal source

🇺🇸Dec 7, 2024Industrycapsida.comTier 1 · Company source

New Preclinical Data Demonstrate Potential of Capsida’s IV Gene Therapy for STXBP1-DEE to Correct all Disease Manifestations

Capsida BiotherapeuticsOriginal source

🇺🇸Dec 6, 2024CRObioagilytix.comTier 2 · Direct publisher

Unraveling the Biosimilar Paradox

BioAgilytixOriginal source

🇪🇬Dec 6, 2024Researchcu.edu.egTier 2 · Direct publisher

Cairo University achieves significant leaps in the Times Arab Rankings for 2024, ranking eighth among Arab universities and first among Egyptian universities.

Cairo UniversityOriginal source

🌍Dec 4, 2024Industrydayonebio.comTier 3 · Secondary coverage

Anna’s story: Navigating life with her son’s brain tumor diagnosis

Mersana TherapeuticsOriginal source

🌍Dec 3, 2024Mediahealx.aiTier 2 · Direct publisher

Jonathan Milner, Ph.D., Appointed as Non-Executive Chairman of Healx

HealxOriginal source

🇺🇸Dec 3, 2024CDMOkbibiopharma.comTier 2 · Direct publisher

KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Antibody Candidate

KBI BiopharmaOriginal source

🌍Dec 3, 2024Industrydayonebio.comTier 3 · Secondary coverage

Nora’s Journey with Pediatric Low-Grade Glioma (pLGG)Test post

Mersana TherapeuticsOriginal source

🌍Dec 2, 2024Regulatoryima.isTier 1 · Regulatory source

Common nordic packages for better availability

IMA IcelandOriginal source

🌍Dec 2, 2024Regulatoryravimiamet.eeTier 1 · Regulatory source

Statistical Yearbook of 2024

SAM EstoniaOriginal source

🇯🇵Dec 2, 2024Devicesglobal.medical.canonTier 1 · Company source

Canon Medical Systems Expands the Boundaries of CT Imaging

Canon Medical SystemsOriginal source

🇺🇸Nov 29, 2024Devicesaccuray.comTier 1 · Company source

The Art of Radiotherapy: What Unusual Patients Have Taught Me

AccurayOriginal source

🇦🇹Nov 27, 2024Devicescontextflow.comTier 1 · Company source

contextflow Set to Secure Europe’s First Radiology AI Reimbursement Contract

contextflow (ADVANCE Chest CT Lung)Original source

🌍Nov 27, 2024Devicesdigitaldiagnostics.comTier 1 · Company source

Digital Diagnostics and Google Cloud Collaborate to Combat Diabetic Retinopathy in the Kingdom of Saudi Arabia

IDx (Digital Diagnostics)Original source

🇺🇸Nov 26, 2024Devicesaccuray.comTier 1 · Company source

Success at Prostate SBRT Course in Miami

AccurayOriginal source

🌍Nov 25, 2024Industryvirtualincision.comTier 1 · Company source

U.S.-Based Remote Robotic-Assisted Surgery Demonstration Successfully Completed Through Collaborations with Virtual Incision, Sovato, City of Hope, and University of Illinois Chicago

Virtual IncisionOriginal source

🇺🇸Nov 25, 2024Industrycapsida.comTier 1 · Company source

Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference

Capsida BiotherapeuticsOriginal source

🇺🇸Nov 22, 2024Devicesaccuray.comTier 1 · Company source

Expanding Radiotherapy Access in Pakistan: An Interview with Dr. Tariq Mahmood

AccurayOriginal source

🇮🇱Nov 22, 2024Industrytevapharm.comTier 1 · Company source

Infographic Economic Impact Report

Teva PharmaceuticalsOriginal source

🇺🇸Nov 21, 2024Industrygenesis.mlTier 3 · Secondary coverage

Boltz-1: Democratizing Biomolecular Interaction Modeling

Genesis TherapeuticsOriginal source

🌍Nov 18, 2024Industrydayonebio.comTier 3 · Secondary coverage

Bradon’s story

Mersana TherapeuticsOriginal source

🇨🇭Nov 18, 2024Industryalentis.chTier 1 · Company source

Alentis Receives FDA Fast Track Designation for ALE.P02 for the Treatment of CLDN1+ Squamous Solid Tumors

Alentis TherapeuticsOriginal source

🌍Nov 15, 2024Devicesdigitaldiagnostics.comTier 1 · Company source

Curiosity Ignited: Showcasing How AI is Accelerating Discoveries

IDx (Digital Diagnostics)Original source

🌍Nov 14, 2024Mediaperspectum.comTier 2 · Direct publisher

Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development

PerspectumOriginal source